Giacomo Chiesi is the Managing Partner of Chiesi Ventures, a venture capital fund he founded in 2014 as a corporate. See sector focus and contact routes.
Giacomo Chiesi is the Managing Partner of Chiesi Ventures, a venture capital fund he founded in 2014 as a corporate venture arm of the Italian family pharmaceutical company Chiesi, and he also leads the group’s Global Rare Diseases division from Boston. His investment thesis targets early-stage biotechnology and pharmaceutical companies developing novel therapies for rare and orphan disorders, with a geographic focus on the United States and Europe. The firm typically invests across small molecules, biologics, and advanced therapies, though specific check sizes and whether Chiesi Ventures leads or follows rounds are not publicly detailed. Notable portfolio companies include Aura Biosciences, Sentien Biotech, Glycomine, and Minoryx Therapeutics, on whose boards Chiesi serves as a member or observer. Chiesi’s distinctive point of view centers on leveraging external innovation to address unmet medical needs in rare diseases, complementing Chiesi Group’s internal drug development efforts. He holds a degree in Telecommunications Engineering from the University of Parma and an MBA from the University of Chicago Booth School of Business with a focus on entr
Every field above is read from the StartupFundraising investor directory — disclosed location, recorded investments and stated focus — and re-checked as filings arrive. Founders pair it with investors in Boston when building a target list.
Investors like Giacomo Chiesi · Full investor directory · Investor access · Company funding database